GOLD 2025 Report - Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2025 Report

Sep 11, 2026

Upload by Anda

Global Initiative for Chronic Obstructive Lung Disease (GOLD) provides the 2025 report outlining a global strategy for diagnosing, managing, and preventing chronic obstructive pulmonary disease. The materials emphasize that clinical relevance and patient applicability must be assessed and determined by qualified health care professionals. The report notes that only the English version has been reviewed and approved, and stresses the need to confirm the most current content version. GOLD expressly disclaims liability related to misuse or misapplication of the information provided.

LanguageEnglish

CategoryPresentations

FormatPDF

Pages215

Reading Time1 h 15 min

AccessFree to download

Important Purpose & Liability Disclaimer

GOLD Governance and Committees

Global Strategy for the Diagnosis, Management, and Prevention of COPD (2025)

Acknowledgements

Global Initiative for Chronic Obstructive Lung Disease 2025 REPORT Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2025 REPORT) © 2024, 2025 Global Initiative for Chronic Obstructive Lung Disease, Inc. Important Purpose & Liability Disclaimer The information provided by Global Initiative for Chronic Obstructive Lung Disease (“GOLD”) for inclusion in its materials, website, and applications (including but not limited to web based or digital applications) is provided for the convenience of users to help them understand the conclusions of GOLD as of the date of the specific information’s approval by GOLD. That information’s relevance to, and/or application to, a particular patient or case must be carefully assessed, evaluated, and determined by a qualified health care professional treating that patient or case. Users need to be aware of the fact that only the English language version of GOLD’s information has been reviewed and approved by GOLD, and that users must ensure that they have the most current version of GOLD’s information since GOLD’s information may have been updated or changed after its original release. Especially in light of the above, GOLD expressly disclaims any liability arising out of any use or misuse of the information it provides. GOLD BOARD OF DIRECTORS (2024) GOLD SCIENCE COMMITTEE* (2024) Alvar Agusti, MD, Chair Respiratory Institute Hospital Clinic, IDIBAPSUniv. Barcelona and Ciberes Barcelona, Spain Bartolome R. Celli, MD Harvard Medical School Boston, Massachusetts, USA Gerard Criner, MD Temple University School of Medicine Philadelphia, Pennsylvania, USA David Halpin, MD University of Exeter Medical School College of Medicine and Health University of Exeter, Exeter Devon, UK Maria Montes de Oca, MD Hospital Universitario de Caracas Universidad Central de Venezuela Centro Médico de Caracas Caracas, Venezuela Obianuju B. Ozoh, MD University of Lagos Lagos, Nigeria Sundeep Salvi, MD Pulmocare Research and Education (PURE) Foundation Pune, India Claus Vogelmeier, MD University of Marburg Marburg, Germany Jinping Zheng, MD Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China GOLD EXECUTIVE DIRECTOR Katie Langefeld, BS Illinois, USA Claus Vogelmeier, MD, Chair University of Marburg Marburg, Germany Alvar Agusti, MD Respiratory Institute Hospital Clinic, IDIBAPSUniv. Barcelona and Ciberes Barcelona, Spain Antonio Anzueto, MD South Texas Veterans Health Care System, University of Texas, Health San Antonio, Texas, USA Jean Bourbeau, MD McGill University Health Centre McGill University Montreal, Canada Gerard Criner, MD Temple University School of Medicine Philadelphia, Pennsylvania, USA David Halpin, MD University of Exeter Medical School College of Medicine and Health University of Exeter, Exeter Devon, UK MeiLan K. Han, MD MS University of Michigan Ann Arbor, MI, USA Fernando J. Martinez, MD MS University of Massachusetts Chan Medical School Worcester, MA, USA Maria Montes de Oca, MD Hospital Universitario de Caracas Universidad Central de Venezuela Centro Médico de Caracas Caracas, Venezuela Obianuju B. Ozoh, MD University of Lagos Lagos, Nigeria EDITORIAL ASSISTANCE Ruth Hadfield, PhD Macquarie University AIHI Sydney, Australia ADMIN ASSISTANCE Ashley Dear Alberto Papi, MD University of Ferrara Ferrara, Italy Ian Pavord, DM FMedSci Respiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine University of Oxford Oxford, UK Nicolas Roche, MD Pneumologie, Hôpital Cochin AP-HP.Centre – Université Paris Cité UMR 1016 Institut Cochin Paris, France

FAQs

What is the purpose of the GOLD 2025 report?

The report provides information to help users understand GOLD conclusions regarding the diagnosis, management, and prevention of COPD, as of the specific information approval date.

How should the report’s recommendations be used in patient care?

Relevance to a particular patient or case must be carefully assessed and evaluated by a qualified health care professional treating that patient.

Which language version is approved, and what must users ensure?

Only the English language version has been reviewed and approved by GOLD; users must ensure they are using the most current version because updates may occur after initial release.

Sep 11, 2026

Upload by Anda